Abstract
A series of new 3,4-dihydronaphthalen-1(2H)-one derivatives (6a–f) were designed, and synthesized by the Claisen–Schmidt condensation reaction. Their structures were characterized by NMR, FTIR, and MS spectroscopy. Their antitumor activities against human neoplastic cell lines Hela, Hepg2, K562, THP-1, SW1990, MIA PaCa-2, NCI-H460 and SK-BR-3 by the MTT method exhibited obvious anticancer activities and their cytotoxicities for LO2 cell lines were lower than DOX, especially for 6b and 6d. The inhibition activities against the Bcl-2 protein for 6b was evaluated and the result shows that lipophilic 3,4-dimethoxybenzylidene and 3,4-dihydronaphthalen-1(2H)-one could bind slightly to the active pockets of the Bcl-2 protein.
Graphical Abstract
Similar content being viewed by others
References
Y. Komohara, M. Jinushi, M. Takeya, Cancer Sci. 105, 1 (2014)
E.A. Mellon, G.M. Springett, S.E. Hoffe, P. Hodul, M.P. Malafa, K.L. Meredith, W.J. Fulp, X. Zhao, R. Shridhar, Cancer 120, 1171 (2014)
A. Bhatt, O. Glehen, Indian J. Surg. Oncol. 7, 188 (2016)
L. Wei, X. Zhang, X.Y. Hu, A.R. Hu, Med. Sci. Monit. 22, 1872 (2016)
A.B. Cook, D.R. Ziazadeh, J. Lu, T.L. Jackson, Math. Biosci. Eng. 12, 1219 (2015)
Z.N. Oltvai, C.L. Milliman, S.J. Korsmeyer, Cell 74, 609 (1993)
Y.H. Yee, S.J. Chong, S. Pervaiz, Biol. Chem. 397, 585 (2016)
A.J. Souers, J.D. Leverson, E.R. Boghaert, S.L. Ackler, N.D. Catron, J. Chen et al., Nat. Med. 19, 202 (2013)
Y.B. Mao, W.J. Cai, J.W. Wang, G.J. Hong, X.Y. Tao, L.J. Wang, Y.P. Huang, X.Y. Chen, Nat. Biotechnol. 25, 1307 (2007)
S. Trudel, Z.H. Li, J. Rauw, R.E. Tiedemann, X.Y. Wen, A.K. Stewart, Blood 109, 5430 (2007)
Y. Wan, S. Wu, G. Xiao, T. Liu, X. Hou, C. Chen, P. Guan, X. Yang, H. Fang, Bioorg. Med. Chem. 23, 1994 (2015)
J.W. Barlow, T. Zhang, O. Woods, A.J. Byrne, J.J. Walsh, Med. Chem. 7, 213 (2011)
A.J. Kirby, L.R. Le, F. Maharlouie, P. Mason, P.J. Nicholls, H.J. Smith, C. Simons, J. Enzyme Inhib. Med. Chem. 18, 27 (2003)
A.D. Kumar, M.P. Kumar, Med. Res. Rev. 30, 818 (2010)
S. Das, U. Das, H. Sakagami, N. Umemura, S. Iwamoto, T. Matsuta, M. Kawase, J. Molnár, J. Serly, D.K.J. Gorecki, Eur. J. Med. Chem. 51, 193 (2012)
Q. Chen, Y. Hou, G.G. Hou, J.F. Sun, N. Li, W. Cong, F. Zhao, H.J. Li, C.H. Wang, Res. Chem. Intermed. 42, 8119 (2016)
B. Zhou, X. Li, Y. Li, Y. Xu, Z. Zhang, M. Zhou, X. Zhang, Z. Liu, J. Zhou, C. Cao, B. Yu, R. Wang, ChemMedChem 6, 904 (2011)
H.A. Aisa, W. Lu, J.C. Cai, Chin. J. Chem. 21, 720 (2003)
F. Ameer, R.G.F. Giles, I.R. Green, R. Pearce, Synth. Commun. 34, 1247 (2004)
Acknowledgement
Our thanks for the binding assay for Bcl-2 proteins by Prof. Xi Hu from Yantai University in China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, F., Zhang, R., Cui, Y. et al. Design, synthesis and biological evaluation of 3,4-dihydronaphthalen-1(2H)-one derivatives as Bcl-2 inhibitors. Res Chem Intermed 43, 5933–5942 (2017). https://doi.org/10.1007/s11164-017-2972-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-017-2972-x